Qiu Qi, Todd Nevins W, Li Ruiyun, Peng Hong, Liu Zhenqiu, Yfantis Harris G, Katz Ruth L, Stass Sanford A, Jiang Feng
Department of Pathology, University of Maryland School of Medicine, 10 South Pine St., MSTF 7th Fl., Baltimore, MD 21201-1192, USA.
Cancer. 2008 Aug 25;114(4):275-83. doi: 10.1002/cncr.23596.
Sputum is an easily accessible diagnostic material for lung cancer early detection by cytologic and molecular genetic analysis of exfoliated airway epithelial cells. However, the use of sputum is limited by its cellular heterogeneity, which includes >95% macrophages and neutrophils and only about 1% bronchial epithelial cells. We propose to obtain concentrated and purified bronchial epithelial cells to improve early detection of lung cancer in sputum samples.
Sputum was collected from patients with stage I nonsmall-cell lung cancer, cancer-free smokers, and healthy nonsmokers. Magnetic-assisted cell sorting (MACS) with anti-CD14 and anti-CD16 antibody beads were used to enrich bronchial epithelial cells by depleting macrophages and neutrophils from sputum. Fluorescence in situ hybridization (FISH) analysis for detection of FHIT deletion and cytology were evaluated in the enriched specimens.
The bronchial epithelial cells were concentrated to 40% purity from 1.1% of the starting population, yielding an average of 36-fold enrichment and at least 2.3 x 10(5) cells per sample. Detecting FHIT deletions for lung cancer diagnosis produced 58% sensitivity in the enriched sputum, whereas there was 42% sensitivity in the unenriched samples (P = .02). Cytologic examination of the enriched sputum resulted in 53% sensitivity, as compared with 39% sensitivity in unenriched sputum (P = .03). Furthermore, only 2 cytocentrifuge slides of the unenriched sputum were needed for the analyses, as compared with up to 10 cytocentrifuge slides required from the unprocessed specimens.
The enrichment of bronchial epithelial cells could improve the diagnostic value of sputum and the efficiency of genetic and cytologic analysis of lung cancer.
痰液是一种易于获取的诊断材料,可通过对脱落气道上皮细胞进行细胞学和分子遗传学分析来实现肺癌的早期检测。然而,痰液的使用受到其细胞异质性的限制,其中包括>95%的巨噬细胞和中性粒细胞,而支气管上皮细胞仅约占1%。我们建议获取浓缩和纯化的支气管上皮细胞,以提高痰液样本中肺癌的早期检测率。
收集I期非小细胞肺癌患者、无癌吸烟者和健康非吸烟者的痰液。使用抗CD14和抗CD16抗体磁珠的磁辅助细胞分选(MACS)技术,通过去除痰液中的巨噬细胞和中性粒细胞来富集支气管上皮细胞。对富集样本进行荧光原位杂交(FISH)分析以检测FHIT基因缺失,并进行细胞学评估。
支气管上皮细胞从起始群体的1.1%浓缩至纯度为40%,平均富集36倍,每个样本至少有2.3×10⁵个细胞。在富集痰液中检测FHIT基因缺失用于肺癌诊断的敏感性为58%,而未富集样本中的敏感性为42%(P = 0.02)。对富集痰液进行细胞学检查的敏感性为53%,而未富集痰液中的敏感性为39%(P = 0.03)。此外,分析未富集痰液仅需2张细胞离心涂片,而未处理样本则需要多达10张细胞离心涂片。
支气管上皮细胞的富集可提高痰液的诊断价值以及肺癌基因和细胞学分析的效率。